• Top Ten most popular articles this week pharmafile
    May 07, 2018
    It's Friday again and it's been a week busy with companies' financials. One company's in particular were of note due to its generics unit's struggles, in the form of Novartis. It then had some bad news broken shortly after its biosimilar failed to impress
PharmaSources Customer Service